Current options for the treatment of optic neuritis

References

• PauDAl ZubidiNYalamanchiliSPlantGTLeeAGOptic neuritisEye (Lond)201125783384221527960
   PubMed Web of Science ®Google Scholar
• BeckRWGalRLBhattiMTVisual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trialAm J Ophthalmol20041371778314700647
   PubMed Web of Science ®Google Scholar
• CostelloFCouplandSHodgeWQuantifying axonal loss after optic neuritis with optical coherence tomographyAnn Neurol200659696396916718705
   PubMed Web of Science ®Google Scholar
• ChanJWEarly diagnosis, monitoring, and treatment of optic neuritisNeurologist2012181233122217611
   PubMed Web of Science ®Google Scholar
• PulaJHRederATMultiple sclerosis. Part I: neuro-ophthalmic manifestationsCurr Opin Ophthalmol200920646747519809319
   PubMed Web of Science ®Google Scholar
• BraughlerJMHallEDMeansEDWatersTRAndersonDKEvaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injuryJ Neurosurg19876711021053598657
   PubMed Web of Science ®Google Scholar
• BrusaferriFCandeliseLSteroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trialsJ Neurol2000247643544210929272
   PubMed Web of Science ®Google Scholar
• SpoorTCRockwellDLTreatment of optic neuritis with intravenous megadose corticosteroids. A consecutive seriesOphthalmology19889511311343344120
   PubMed Web of Science ®Google Scholar
• BeckRWClearyPAAndersonMMJrOptic Neuritis Study GroupA randomized, controlled trial of corticosteroids in the treatment of acute optic neuritisN Engl J Med199232695815881734247
   PubMed Web of Science ®Google Scholar
• VolpeNJThe optic neuritis treatment trial: a definitive answer and profound impact with unexpected resultsArch Ophthalmol2008126799699918625952
   PubMedGoogle Scholar
• BeckRWGalRLTreatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trialArch Ophthalmol2008126799499518625951
   PubMedGoogle Scholar
• GalRLVedulaSSBeckRCorticosteroids for treating optic neuritisCochrane Database Syst Rev20124CD00143022513900
   PubMed Web of Science ®Google Scholar
• DimitriuCBachMLagrezeWAJehleTMethylprednisolone fails to preserve retinal ganglion cells and visual function after ocular ischemia in ratsInvest Ophthalmol Vis Sci200849115003500718586870
   PubMed Web of Science ®Google Scholar
• Optic Neuritis Study GroupMultiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-upArch Neurol200865672773218541792
   PubMedGoogle Scholar
• DuttMTabuenaPVenturaERostamiAShindlerKSTiming of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritisInvest Ophthalmol Vis Sci20105131439144519892867
   PubMed Web of Science ®Google Scholar
• PlantGTSibtainNAThomasDHyperacute corticosteroid treatment of optic neuritis at the onset of pain may prevent visual loss: a case seriesMult Scler Int2011201181506822096643
   PubMedGoogle Scholar
• KaufmanDIAcute optic neuritisCurr Treat Options Neurol199911444811096694
   PubMedGoogle Scholar
• FrohmanEMShahAEggenbergerEMetzLZivadinovRStuveOCorticosteroids for multiple sclerosis: I. Application for treating exacerbationsNeurotherapeutics20074461862617920542
   PubMed Web of Science ®Google Scholar
• PerumalJSCaonCHrehaSOral prednisone taper following intravenous steroids fails to improve disability or recovery from relapses in multiple sclerosisEur J Neurol200815767768018459972
   PubMed Web of Science ®Google Scholar
• MenonVMehrotraASaxenaRJafferyNFComparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritisIndian J Ophthalmol200755535535917699944
   PubMedGoogle Scholar
• CataniaAGattiSColomboGLiptonJMTargeting melanocortin receptors as a novel strategy to control inflammationPharmacol Rev200456112915001661
   PubMed Web of Science ®Google Scholar
• AtkinsEJDrews-BotschCDNewmanNJCalvettiOSwansonSBiousseVManagement of optic neuritis in Canada: survey of ophthalmologists and neurologistsCan J Neurol Sci200835217918418574931
   PubMed Web of Science ®Google Scholar
• BiousseVCalvettiODrews-BotschCDManagement of optic neuritis and impact of clinical trials: an international surveyJ Neurol Sci20092761–2697418926549
   PubMed Web of Science ®Google Scholar
• RioJComabellaMMontalbanXMultiple sclerosis: current treatment algorithmsCurr Opin Neurol201124323023721499098
   PubMed Web of Science ®Google Scholar
• FoxERhoadesRNew treatments and treatment goals for patients with relapsing-remitting multiple sclerosisCurr Opin Neurol201225SupplS11S1922398660
   PubMed Web of Science ®Google Scholar
• ShamsPNPlantGTOptic neuritis: a reviewInt MS J2009163828919878630
   PubMedGoogle Scholar
• GwathmeyKBalogunRABurnsTNeurologic indications for therapeutic plasma exchange: an updateJ Clin Apher201126526126821915895
   PubMed Web of Science ®Google Scholar
• BronzlikPTotoSKielsteinJTSchmidtBMWStangelMTrebstCTherapeutic plasma exchange and immunoadsorption therapy in neurological diseasesEur Neurol J2011315661
   Google Scholar
• TrebstCReisingAKielsteinJTHaferCStangelMPlasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosisBlood Purif200928210811519521072
   PubMed Web of Science ®Google Scholar
• RoesnerSAppelRGbadamosiJMartinRHeesenCTreatment of steroid-unresponsive optic neuritis with plasma exchangeActa Neurol Scand1122011 [Epub ahead of print.]
   Web of Science ®Google Scholar
• KoziolekMJTampeDBahrMImmunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritisJ Neuroinflammation2012918022537481
   PubMed Web of Science ®Google Scholar
• TselisAPerumalJCaonCTreatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulinEur J Neurol200815111163116718727675
   PubMed Web of Science ®Google Scholar
• BunyanRFTangJWeinshenkerBAcute demyelinating disorders: emergencies and managementNeurol Clin201230128530722284064
   PubMed Web of Science ®Google Scholar
• WeinshenkerBGO’BrienPCPettersonTMA randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating diseaseAnn Neurol199946687888610589540
   PubMed Web of Science ®Google Scholar
• PradhanSGuptaRPShashankSPandeyNIntravenous immunoglobulin therapy in acute disseminated encephalomyelitisJ Neurol Sci19991651566110426148
   PubMed Web of Science ®Google Scholar
• TsakiriAKallenbachKFugloDWanscherBLarssonHFrederiksenJSimvastatin improves final visual outcome in acute optic neuritis: a randomized studyMult Scler2012181728121921071
   PubMed Web of Science ®Google Scholar
• Borhani-HaghighiAGhodsiMRazeghinejadMRErythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination eventNeurosciences (Riyadh)201217215115522465890
   PubMed Web of Science ®Google Scholar
• SuhsKWHeinKSattlerMBErythropoietin as add-on therapy to methylprednisolone in patients with acute autoimmune optic neuritis: a randomised, double-blind, placebo-controlled, phase 2 parallel group studyPaper presented at: 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple SclerosisOctober 19–22, 2011Amsterdam, The Netherlands
   Google Scholar
• SudhalkarAKhamarMKhamarBOutcomes of toll-like receptors’ antagonism in steroid-resistant optic neuritis; a pilot studyGraefes Arch Clin Exp Ophthalmol2012250687187622169982
   PubMed Web of Science ®Google Scholar
• RauCRHeinKSattlerMBAnti-inflammatory effects of FTY720 do not prevent neuronal cell loss in a rat model of optic neuritisAm J Pathol201117841770178121406175
   PubMed Web of Science ®Google Scholar
• EsfahaniMRHarandiZAMovasatMMemantine for axonal loss of optic neuritisGraefes Arch Clin Exp Ophthalmol2012250686386922173217
   PubMed Web of Science ®Google Scholar
• HickmanSJKoMChaudhryFJayWMPlantGTOptic neuritis: an update typical and atypical optic neuritisNeuroophthalmology2008325237248
   Web of Science ®Google Scholar
• MillerNRNewmanNJWalsh and Hoyt’s Clinical Neuro- ophthalmology5th edBaltimore, MDLippincott Williams and Wilkins1998599648
   Google Scholar
• RodriguezMSilvaACrossSAO’BrienPCKurlandLTOptic neuritis: a population-based study in Olmstead County, MinnesotaNeurology19954522442507854520
   PubMed Web of Science ®Google Scholar
• FriguiMFrikhaFSellemiDChouayakhFFekiJBahloulZOptic neuropathy as a presenting feature of systemic lupus erythematosus: two case reports and literature reviewLupus201120111214121821669911
   PubMed Web of Science ®Google Scholar
• FrohmanLDellatorreKTurbinRBieloryLClinical characteristics, diagnostic criteria and therapeutic outcomes in autoimmune optic neuropathyBr J Ophthalmol200993121660166619692378
   PubMed Web of Science ®Google Scholar
• KupersmithMJBurdeRMWarrenFAKlingeleTGFrohmanLPMitnickHAutoimmune optic neuropathy: evaluation and treatmentJ Neurol Neurosurg Psychiatry19885111138113863266235
   PubMed Web of Science ®Google Scholar
• KiddDBurtonBPlantGTGrahamEMChronic relapsing inflammatory optic neuropathy (CRION)Brain2003126Pt 227628412538397
   PubMed Web of Science ®Google Scholar
• HackettERMartinezRDLarsonPFPaddisonRMOptic neuritis in systemic lupus erythematosusArch Neurol19743119114834535
   PubMedGoogle Scholar
• CinefroRJFrenkelMSystemic lupus erythematosus presenting as optic neuritisAnn Ophthalmol1978105559563677640
   PubMedGoogle Scholar
• SmithCAPinalsRSOptic neuritis in systemic lupus erythematosusJ Rheumatol1982969639667161791
   PubMed Web of Science ®Google Scholar
• JabsDAMillerNRNewmanSAJohnsonMAStevensMBOptic neuropathy in systemic lupus erythematosusArch Ophthalmol198610445645683954662
   PubMedGoogle Scholar
• SiatkowskiRMScottIUVermAMOptic neuropathy and chiasmopathy in the diagnosis of systemic lupus erythematosusJ Neuroophthalmol200121319319811725184
   PubMed Web of Science ®Google Scholar
• SmithCHOptic neuritisMillerNRNewmanNJWalsh and Hoyt’s Clinical Neuro-Ophthalmology6th edBaltimore, MDLippincott Williams and Wilkins2005293348
   Google Scholar
• LinYCWangAGYenMYSystemic lupus erythematosus-associated optic neuritis: clinical experience and literature reviewActa Ophthalmol200987220421018507726
   PubMed Web of Science ®Google Scholar
• TamesisRRRodriguezAChristenWGAkovaYAMessmerEFosterCSSystemic drug toxicity trends in immunosuppressive therapy of immune and inflammatory ocular diseaseOphthalmology199610357687758637685
   PubMed Web of Science ®Google Scholar
• RosenbaumJTSimpsonJNeuweltCMSuccessful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamideBr J Ophthalmol19978121301329059246
   PubMed Web of Science ®Google Scholar
• Galindo-RodriguezGAvina-ZubietaJAPizar roSCyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: an open trialAm J Med19991061656910320119
   PubMed Web of Science ®Google Scholar
• GoodwinJAutoimmune optic neuropathyCurr Neurol Neurosci Rep20066539640216928350
   PubMed Web of Science ®Google Scholar
• AndersonGColesETCraneMWegener’s granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a subcommittee of the British Thoracic Society Research CommitteeQ J Med1992833024274381448544
   PubMedGoogle Scholar
• HuchzermeyerCMardinCHolbachLZwerinaJSchettGRechJSuccessful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener’s granulomatosisClin Rheumatol9232010 [Epub ahead of print.]
   Google Scholar
• MonteiroMLBorgesWIdo Val Ferreira RamosCLucatoLTLeiteCCBilateral optic neuritis in Wegener granulomatosisJ Neuroophthalmol2005251252815756129
   PubMed Web of Science ®Google Scholar
• AgboguBNSternBJSewellCYangGTherapeutic considerations in patients with refractory neurosarcoidosisArch Neurol19955298758797661724
   PubMedGoogle Scholar
• BaughmanRPLowerEEInfliximab for refractory sarcoidosisSarcoidosis Vasc Diffuse Lung Dis2001181707411354550
   PubMed Web of Science ®Google Scholar
• MohanNEdwardsETCuppsTRDemyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritidesArthritis Rheum200144122862286911762947
   PubMed Web of Science ®Google Scholar
• MyersTDSmithJRWertheimMSEganRAShultsWTRosenbaumJTUse of corticosteroid sparing systemic immunosuppression for treatment of corticosteroid dependent optic neuritis not associated with demyelinating diseaseBr J Ophthalmol200488567368015090422
   PubMed Web of Science ®Google Scholar
• FrisenLLindgrenSMacGregorBJStattinSSarcoid-like disorder of the intracranial optic nerveJ Neurol Neurosurg Psychiatry1977407702707199708
   PubMed Web of Science ®Google Scholar
• GrahamEMEllisCJSandersMDMcDonaldWIOptic neuropathy in sarcoidosisJ Neurol Neurosurg Psychiatry19864977567633746306
   PubMed Web of Science ®Google Scholar
• GudemanSKSelhorstJBSusacJOWaybrightEASarcoid optic neuropathyNeurology19823265976037201090
   PubMed Web of Science ®Google Scholar
• CollonguesNMarignierRZephirHNeuromyelitis optica in France: a multicenter study of 125 patientsNeurology201074973674220194912
   PubMed Web of Science ®Google Scholar
• WingerchukDMHogancampWFO’BrienPCWeinshenkerBGThe clinical course of neuromyelitis optica (Devic’s syndrome)Neurology19995351107111410496275
   PubMed Web of Science ®Google Scholar
• WingerchukDMPittockSJLucchinettiCFLennonVAWeinshenkerBGA secondary progressive clinical course is uncommon in neuromyelitis opticaNeurology200768860360517310032
   PubMed Web of Science ®Google Scholar
• LennonVAWingerchukDMKryzerTJA serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosisLancet200436494512106211215589308
   PubMed Web of Science ®Google Scholar
• WingerchukDMLennonVAPittockSJLucchinettiCFWeinshenkerBGRevised diagnostic criteria for neuromyelitis opticaNeurology200666101485148916717206
   PubMed Web of Science ®Google Scholar
• TakahashiTFujiharaKNakashimaIAnti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titreBrain2007130Pt 51235124317449477
   PubMed Web of Science ®Google Scholar
• LaiCTianGLiuWWeiWTakahashiTZhangXClinical characteristics, therapeutic outcomes of isolated atypical optic neuritis in ChinaJ Neurol Sci20113051–2384021470641
   PubMed Web of Science ®Google Scholar
• MerleHOlindoSDonnioARicherRSmadjaDCabrePRetinal peripapillary nerve fiber layer thickness in neuromyelitis opticaInvest Ophthalmol Vis Sci200849104412441718614811
   PubMed Web of Science ®Google Scholar
• GreenAJCreeBADistinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritisJ Neurol Neurosurg Psychiatry20098091002100519465415
   PubMed Web of Science ®Google Scholar
• NaismithRTTutlamNTXuJOptical coherence tomography differs in neuromyelitis optica compared with multiple sclerosisNeurology200972121077108219307541
   PubMed Web of Science ®Google Scholar
• NakamuraMNakazawaTDoiHEarly high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis opticaGraefes Arch Clin Exp Ophthalmol2010248121777178520300766
   PubMed Web of Science ®Google Scholar
• WatanabeSNakashimaIMisuTTherapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis opticaMult Scler200713112813217294622
   PubMed Web of Science ®Google Scholar
• YoshidaHAndoAShoKAnti-aquaporin-4 antibody-positive optic neuritis treated with double-filtration plasmapheresisJ Ocul Pharmacol Ther201026438138520698801
   PubMed Web of Science ®Google Scholar
• KeeganMPinedaAAMcClellandRLDarbyCHRodriguezMWeinshenkerBGPlasma exchange for severe attacks of CNS demyelination: predictors of responseNeurology200258114314611781423
   PubMed Web of Science ®Google Scholar
• MiyamotoKKusunokiSIntermittent plasmapheresis prevents recurrence in neuromyelitis opticaTher Apher Dial200913650550819954473
   PubMed Web of Science ®Google Scholar
• Van den BerghPKHaddenRMBouchePEuropean Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – First RevisionEuropean Journal of Neurology20101735636320456730
   PubMed Web of Science ®Google Scholar
• CollonguesNde SezeJCurrent and future treatment approaches for neuromyelitis opticaTher Adv Neurol Disord20114211112121694808
   PubMedGoogle Scholar
• MandlerRNAhmedWDencoffJEDevic’s neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprineNeurology1998514121912209781568
   PubMed Web of Science ®Google Scholar
• CostanziCMatielloMLucchinettiCFAzathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis opticaNeurology201177765966621813788
   PubMed Web of Science ®Google Scholar
• BichuettiDBLobato de OliveiraEMOliveiraDMAmorin de SouzaNGabbaiAANeuromyelitis optica treatment: analysis of 36 patientsArch Neurol20106791131113620837859
   PubMedGoogle Scholar
• WatanabeSMisuTMiyazawaILow-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysisMult Scler200713896897417623727
   PubMed Web of Science ®Google Scholar
• KimSHKimWLiXFJungIJKimHJRepeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 yearsArch Neurol201168111412142021747007
   PubMedGoogle Scholar
• GreenbergBMGravesDRemingtonGRituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic successMult Scler1192012 [Epub ahead of print.]
   Web of Science ®Google Scholar
• CreeBALambSMorganKChenAWaubantEGenainCAn open label study of the effects of rituximab in neuromyelitis opticaNeurology20056471270127215824362
   PubMed Web of Science ®Google Scholar
• JacobAWeinshenkerBGViolichITreatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patientsArch Neurol200865111443144818779415
   PubMed Web of Science ®Google Scholar
• BediGSBrownADDelgadoSRUsmaniNLamBLSheremataWAImpact of rituximab on relapse rate and disability in neuromyelitis opticaMult Scler201117101225123021622594
   PubMed Web of Science ®Google Scholar
• LindseyJWMeulmesterKMBrodSANelsonFWolinskyJSVariable results after rituximab in neuromyelitis opticaJ Neurol Sci20123171–210310522405926
   PubMed Web of Science ®Google Scholar
• CapobiancoMMalucchiSdi SapioAVariable responses to rituximab treatment in neuromyelitis optica (Devic’s disease)Neurol Sci200728420921117690854
   PubMed Web of Science ®Google Scholar
• JariusSAboul-EneinFWatersPAntibody to aquaporin-4 in the long-term course of neuromyelitis opticaBrain2008131Pt 113072308018945724
   PubMed Web of Science ®Google Scholar
• NasirSKerrDABirnbaumJNineteen episodes of recurrent myelitis in a woman with neuromyelitis optica and systemic lupus erythematosusArch Neurol20096691160116319752308
   PubMedGoogle Scholar
• FalciniFTrapaniSRicciLRestiMSimoniniGde MartinoMSustained improvement of a girl affected with Devic’s disease over 2 years of mycophenolate mofetil treatmentRheumatology (Oxford)200645791391516638802
   PubMed Web of Science ®Google Scholar
• JacobAMatielloMWeinshenkerBGTreatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patientsArch Neurol20096691128113319752302
   PubMedGoogle Scholar
• MokCCToCHMakAPoonWLImmunoablative cyclophosphamide for refractory lupus-related neuromyelitis opticaJ Rheumatol200835117217418176991
   PubMed Web of Science ®Google Scholar
• BirnbaumJKerrDOptic neuritis and recurrent myelitis in a woman with systemic lupus erythematosusNat Clin Pract Rheumatol20084738138618493269
   PubMedGoogle Scholar
• KleiterIHellwigKBertheleAFailure of natalizumab to prevent relapses in neuromyelitis opticaArch Neurol201269223924522332191
   PubMedGoogle Scholar
• BradyKMBrarASLeeAGCoatsDKPaysseEASteinkullerPGOptic neuritis in children: clinical features and visual outcomeJ AAPOS1999329810310221803
   PubMed Web of Science ®Google Scholar
• SpaliceAProperziELo FaroVAcamporaBIannettiPIntravenous immunoglobulin and interferon: successful treatment of optic neuritis in pediatric multiple sclerosisJ Child Neurol200419862362615605474
   PubMed Web of Science ®Google Scholar
• CoylePKPediatric multiple sclerosis: just like their elders?Arch Neurol201168441942121482921
   PubMedGoogle Scholar
• BonhommeGRMitchellEBTreatment of pediatric optic neuritisCurr Treat Options Neurol20121419310222190178
   PubMed Web of Science ®Google Scholar
• MoralesDSSiatkowskiRMHowardCWWarmanROptic neuritis in childrenJ Pediatr Ophthalmol Strabismus200037525425911020105
   PubMed Web of Science ®Google Scholar
• SubramanianPSPediatric optic neuritis and multiple sclerosis: who is at risk for progression?J AAPOS201115541942021958904
   PubMed Web of Science ®Google Scholar
• MahmoodNASilverKOnelKKoMJavedAEfficacy and safety of rituximab in pediatric neuromyelitis opticaJ Child Neurol201126224424721183724
   PubMed Web of Science ®Google Scholar
• JoDHKimSJChaeJHYuYSThe clinical characteristics of optic neuritis in Korean childrenKorean J Ophthalmol201125211612021461224
   PubMedGoogle Scholar
• SonnevilleRKleinIFWolffMUpdate on investigation and management of postinfectious encephalitisCurr Opin Neurol201023330030420442573
   PubMed Web of Science ®Google Scholar
• SejvarJJAcute disseminated encephalomyelitisCurr Infect Dis Rep200810430731418765104
   PubMed Web of Science ®Google Scholar
• KotlusBSSlavinMLGuthrieDSKodsiSROphthalmologic manifestations in pediatric patients with acute disseminated encephalomyelitisJ AAPOS20059217918315838448
   PubMed Web of Science ®Google Scholar
• PohlDEpidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditionsCurr Opin Neurol200821336637218451724
   PubMed Web of Science ®Google Scholar
• WenderMJAcute disseminated encephalomyelitis (ADEM)J Neuroimmunol20112311–2929921237518
   PubMed Web of Science ®Google Scholar
• NishikawaMIchiyamaTHayashiTOuchiKFurukawaSIntravenous immunoglobulin therapy in acute disseminated encephalomyelitisPediatr Neurol199921258358610465150
   PubMed Web of Science ®Google Scholar
• FerreroSPrettaSRagniNMultiple sclerosis: management issues during pregnancyEur J Obstet Gynecol Reprod Biol200411513915223156
   PubMed Web of Science ®Google Scholar
• LeeMO’BrienPPregnancy and multiple sclerosisJ Neurol Neurosurg Psychiatry200879121308131119010945
   PubMed Web of Science ®Google Scholar
• AchironAKishnerIDolevMEffect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosisJ Neurol200425191133113715372259
   PubMed Web of Science ®Google Scholar
• ConfavreuxCIntravenous immunoglobulins, pregnancy and multiple sclerosisJ Neurol200425191138113915372260
   PubMed Web of Science ®Google Scholar
• DittrichESchmaldienstSLangerMJansenMHorlWHDerflerKImmunoadsorption and plasma exchange in pregnancyKidney Blood Press Res200225423223912424425
   PubMed Web of Science ®Google Scholar
• BourreBMarignierZephirHNeuromyelitis optica and pregnancyNeurology2012781287587922402855
   PubMed Web of Science ®Google Scholar
• KimWKimSHNakashimaIInfluence of pregnancy on neuromyelitis optica spectrum disordersNeurology201278161264126722491862
   PubMed Web of Science ®Google Scholar
• ShangWLiuJNeuromyelitis optica during pregnancyInt J Gynaecol Obstet20111151666821782174
   PubMed Web of Science ®Google Scholar